Company page

Gensight Biologics Sa

Gensight Biologics Sa is a public company listed on the French market under the ticker SIGHT, with a market capitalization of approximately €23.99 million. The company focuses on developing innovative gene therapies for retinal diseases. Gensight aims to address unmet medical needs through its advanced research and development initiatives.